Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:27:09.166Z.
Consensus retrieved: 2026-10-06T13:48:28.461Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:27:09.166Z.
Quote observation: 2026-10-06T19:24:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c1ebec02882b5d134f555e456bf3ec52d4d7fba3d3c39a772b469d051cfe6f8
Forward PE Ratio (N/A) = Dated Quote Price ($2.81) / Consensus Forward EPS ($-3.51)
FORWARD PE RATIO
N/A
Seres Therapeutics, Inc.
Market Cap
$27.21M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | $27.21M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.86M | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.82M | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.94M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $25.57M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $29.88M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.07M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.15M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $2.81, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-3.51 | $-7.38 – $0.35 | 1 | n/m |
| 2027-12-31 | $-4.94 | $-10.38 – $0.49 | 1 | n/m |
| 2028-12-31 | $-4.97 | $-7.78 – $-2.17 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
